We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORMP icon
4176
Oramed Pharmaceuticals
ORMP
$183M
$1.52M ﹤0.01%
69,186
-132,034
-66% -$2.25M
INDIW
4177
CALL
DELISTED
indie Semiconductor, Inc. Warrant
INDIW
$1.52M ﹤0.01%
429,600
+325,000
+311% +$759K
AHRT
4178
AH Realty Trust
AHRT
$539M
$1.52M ﹤0.01%
+113,629
New +$1.5M
GRFS
4179
CALL
Grifois
GRFS
$5.49B
$1.52M ﹤0.01%
+103,900
New +$1.57M
HCICU
4180
DELISTED
Hennessy Capital Investment Corp. V Units
HCICU
$1.52M ﹤0.01%
149,123
-26,068
-15% -$269K
RNAC icon
4181
Cartesian Therapeutics
RNAC
$237M
$1.51M ﹤0.01%
12,143
-30,022
-71% -$3.63M
DRH icon
4182
Diamondrock Hospitality Co
DRH
$2.72B
$1.51M ﹤0.01%
159,896
-37,598
-19% -$336K
UHT
4183
Universal Health Realty Income Trust
UHT
$587M
$1.51M ﹤0.01%
27,331
-2,838
-9% -$167K
FA icon
4184
First Advantage
FA
$3.54B
$1.51M ﹤0.01%
79,276
-32,649
-29% -$686K
APTO
4185
DELISTED
Aptose Biosciences, Inc.
APTO
$1.51M ﹤0.01%
1,539
+838
+120% +$1.05M
RSVR
4186
Reservoir Media
RSVR
$662M
$1.51M ﹤0.01%
165,588
-367,058
-69% -$3.22M
CENQU
4187
DELISTED
CENAQ Energy Corp. Unit
CENQU
$1.51M ﹤0.01%
+150,000
New +$1.5M
SAFM
4188
CALL
DELISTED
Sanderson Farms Inc
SAFM
$1.51M ﹤0.01%
+8,000
New +$1.51M
PSQH icon
4189
PSQ Holdings
PSQH
$16.1M
$1.5M ﹤0.01%
+10,367
New +$1.5M
ISTR icon
4190
Investar Holding Corp
ISTR
$421M
$1.5M ﹤0.01%
68,273
-67,771
-50% -$1.51M
KGC icon
4191
PUT
Kinross Gold
KGC
$28B
$1.5M ﹤0.01%
280,000
GAP
4192
The Gap Inc
GAP
$7.42B
$1.5M ﹤0.01%
66,109
-25,627
-28% -$708K
MSM icon
4193
MSC Industrial Direct
MSM
$7.08B
$1.5M ﹤0.01%
18,702
+9,736
+109% +$827K
OPEN icon
4194
Opendoor
OPEN
$3.97B
$1.5M ﹤0.01%
75,478
-445,455
-86% -$7.2M
DNA.WS
4195
CALL
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$1.5M ﹤0.01%
+442,015
New +$1.57M
FBRX icon
4196
Forte Biosciences
FBRX
$1.57B
$1.5M ﹤0.01%
20,210
+19,447
+2,549% +$10.8M
AIFU
4197
AIFU Inc
AIFU
$220M
$1.5M ﹤0.01%
311
+247
+386% +$1.38M
SCOAU
4198
DELISTED
ScION Tech Growth I Unit
SCOAU
$1.5M ﹤0.01%
150,002
-4
-0% -$40
INSW icon
4199
International Seaways
INSW
$4.58B
$1.49M ﹤0.01%
+81,863
New +$1.4M
OPT
4200
DELISTED
Opthea Limited American Depositary Shares
OPT
$1.49M ﹤0.01%
186,179
-8,155
-4% -$61.9K

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.